Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation

Study Identifier
P19-454
CT.gov Identifier
NCT03868163
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Hepatitis
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Treatment-naïve or - pegIFN (or IFN), and/or Ribavirin (RBV) and/or sofosbuvir (PRS) experienced with confirmed CHC, genotypes 1, 2, 3, 4, 5, or 6, with or without compensated cirrhosis, receiving combination therapy with the all oral GLE/PIB regimen according to standard of care, international guidelines and in line with the current local label. * May be enrolled up to 4 weeks after treatment initiation. * Patients must voluntarily sign and date Informed Consent Form prior to inclusion into the study, * Patient must not be participating or intending to participate in a concurrent interventional therapeutic trial.
    Exclusion Criteria:
    * None.

    Protocol Summary

    This study seeks to assess the effectiveness of Glecaprevir plus Pibrentasvir in participants with chronic hepatitis C in a real-life setting across clinical practice populations in the Russian Federation.

    Study Locations

    Location
    Status
    Location
    LLC Medical Company Hepatolog /ID# 212384
    Samara, Samara Oblast, Russian Federation, 443063
    Status
    Not applicable
    Location
    Professor Pasechnikov Gastroenterology and Pankreatology clinic /ID# 217035
    Stavropol, Stavropol Kray, Russian Federation, 355035
    Status
    Not applicable
    Location
    A. F. Agafonov Republican Clin /ID# 212381
    Kazan', Tatarstan, Respublika, Russian Federation, 420140
    Status
    Not applicable
    Location
    South Ural State Medical univ /ID# 212020
    Chelyabinsk, Russian Federation, 454052
    Status
    Not applicable
    Location
    Clinical Inf. Dis Hospital 1 /ID# 217033
    Novosibirsk, Russian Federation, 630099
    Status
    Not applicable
    Location
    SIH Orlovskiy region city hospital named after S.P. Botkin /ID# 212383
    Oryol, Russian Federation, 302038
    Status
    Not applicable
    Showing {first} - {last} of {total} Results